The role of chronic inflammation in cardiovascular mortality of uremic patients.
Panichi
V
V
Department of Internal Medicine University of Pisa, Pisa, Italy. vpanichi@int.med.unipi.it
Taccola
D
D
Migliori
M
M
Consani
C
C
Giovannini
L
L
Tetta
C
C
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007249:Inflammation / Q000150:complications* / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000453:epidemiology; D015995:Prevalence; D006435:Renal Dialysis; D012307:Risk Factors; D014511:Uremia / Q000150:complications* / Q000453:epidemiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002097:C-Reactive Protein; D001241:Aspirin